Idexx Laboratories (IDXX) Receivables - Net (2009 - 2026)

Idexx Laboratories' Receivables - Net history runs 18 years deep, the most recent figure standing at $603.5 million for Q1 2026.

• In Q1 2026, Receivables - Net rose 14.42% year-over-year to $603.5 million; the TTM figure through Mar 2026 stood at $603.5 million (up 14.42% YoY), while the FY2025 annual figure was $552.4 million, up 16.64% from the prior year.
• Receivables - Net was $603.5 million for Q1 2026 at Idexx Laboratories, up from $552.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $603.5 million in Q1 2026 to a low of $388.1 million in Q3 2022.
• Historically, Receivables - Net has averaged $485.8 million across 5 years, with a median of $473.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net gained 3.0% in 2022, then rose 16.65% in 2023.
• A 5-year view of Receivables - Net shows it stood at $400.6 million in 2022, then rose by 14.18% to $457.4 million in 2023, then grew by 3.53% to $473.6 million in 2024, then advanced by 16.64% to $552.4 million in 2025, then grew by 9.26% to $603.5 million in 2026.
• The last three Receivables - Net figures came in at $603.5 million (Q1 2026), $552.4 million (Q4 2025), and $566.9 million (Q3 2025), per Business Quant data.